APA (7th ed.) Citation

Chung, H., Villanueva, L., Graham, D., Saada-Bouzid, E., Ghori, R., Kubiak, P., . . . Gomez-Roca, C. (2021). P-139 A phase 2 multicohort study (LEAP-005) of lenvatinib plus pembrolizumab in patients with previously treated selected solid tumors: Pancreatic cancer cohort. Annals of Oncology, 32, S146. https://doi.org/10.1016/j.annonc.2021.05.194

Chicago Style (17th ed.) Citation

Chung, H., L. Villanueva, D. Graham, E. Saada-Bouzid, R. Ghori, P. Kubiak, B. Gumuscu, N. Lerman, and C. Gomez-Roca. "P-139 A Phase 2 Multicohort Study (LEAP-005) of Lenvatinib Plus Pembrolizumab in Patients with Previously Treated Selected Solid Tumors: Pancreatic Cancer Cohort." Annals of Oncology 32 (2021): S146. https://doi.org/10.1016/j.annonc.2021.05.194.

MLA (9th ed.) Citation

Chung, H., et al. "P-139 A Phase 2 Multicohort Study (LEAP-005) of Lenvatinib Plus Pembrolizumab in Patients with Previously Treated Selected Solid Tumors: Pancreatic Cancer Cohort." Annals of Oncology, vol. 32, 2021, p. S146, https://doi.org/10.1016/j.annonc.2021.05.194.